IOVA icon

Iovance Biotherapeutics

242 hedge funds and large institutions have $3.88B invested in Iovance Biotherapeutics in 2021 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 92 increasing their positions, 87 reducing their positions, and 23 closing their positions.

Holders
242
Holders Change
+10
Holders Change %
+4.31%
% of All Funds
4.25%
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
34
Increased
92
Reduced
87
Closed
23
Calls
$50.3M
Puts
$30.6M
Net Calls
+$19.6M
Net Calls Change
-$21M
Name Market Value Shares Shares
Change
Shares
Change %
Marshall Wace
251
Marshall Wace
United Kingdom
-17,867 Closed
N
252
Natixis
France
-11,131 Closed
Russell Investments Group
253
Russell Investments Group
United Kingdom
-11,073 Closed
BC
254
Bridgefront Capital
Texas
-9,391 Closed
RJFSA
255
Raymond James Financial Services Advisors
Florida
-8,888 Closed
KM
256
Kalos Management
Georgia
-8,450 Closed
CAN
257
Claraphi Advisory Network
United States
-8,218 Closed
CAG
258
Crestwood Advisors Group
Massachusetts
-8,000 Closed
CCA
259
Checchi Capital Advisers
California
-8,000 Closed
PAM
260
Panagora Asset Management
Massachusetts
-3,336 Closed
ATC
261
Adirondack Trust Company
New York
-65 Closed
PCG
262
Private Capital Group
Connecticut
-53 Closed
TWA
263
TCI Wealth Advisors
Arizona
-17 Closed
EVM
264
Eaton Vance Management
Massachusetts
$0 2,000
Simplex Trading
265
Simplex Trading
Illinois
Parallax Volatility Advisers
266
Parallax Volatility Advisers
California
TCM
267
Tradewinds Capital Management
Washington
$0 3
SM
268
SG3 Management
Puerto Rico
CCM
269
CloudAlpha Capital Management
Hong Kong
PI
270
PEAK6 Investments
Illinois
CFGS
271
Concourse Financial Group Securities
Alabama
Millennium Management
272
Millennium Management
New York
Nomura Asset Management
273
Nomura Asset Management
Japan